Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs
L. MANCEAU, J. RICHARD ALBERT, P.-L. LOLLINI, M. V. C. GREENBERG, P. GILARDI-HEBENSTREIT, V. Ribes
Abstract
The hallmarks of the alveolar subclass of rhabdomyosarcoma are chromosomal translocations that generate chimeric PAX3-FOXO1 or PAX7-FOXO1 transcription factors. Both PAX-FOXO1s result in related cell transformation in animal models, but both mutations are associated with distinct pathological manifestations in patients. To assess the mechanisms underlying these differences, we generated isogenic fibroblast lines expressing either PAX-FOXO1 paralog. Mapping of their genomic recruitment using CUT&Tag revealed that the two chimeric proteins have distinct DNA binding preferences. In addition, PAX7-FOXO1 causes stronger de novo transactivation of its bound regions than PAX3-FOXO1, resulting in greater transcriptomic dynamics involving genes regulating cell shape and cycle. Consistently, PAX3-FOXO1 accentuates fibroblast cellular traits associated with contractility and surface adhesion and limits entry into M phase. In contrast, PAX7-FOXO1 drives cells to adopt an amoeboid shape, reduces entry into S phase, and causes more genomic instabilities. Altogether, our results argue that the diversity of rhabdomyosarcoma manifestation arises, in part, from the divergence between the transcriptional activities of PAX3-FOXO1 and PAX7-FOXO1. Furthermore, the identified pronounced deleterious effects of PAX7-FOXO1 provide an explanation for the low frequency of the translocation generating this factor in patients with rhabdomyosarcoma.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fusion transcription factor dosage controls cell state in rhabdomyosarcoma
Rachel A. Hoffman, Meng Wang, … Benjamin Z. Stanton·bioRxiv·May 16, 2025
- Myogenic and neural transcriptional circuitry determines PAX3::FOXO1 driven initiation of rhabdomyosarcoma
Bradley T. Stevens, Yang Zhang, … Mark E. Hatley·bioRxiv·Oct 29, 2026
- The PAXFOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition
G. GONZALEZ CURTO, A. Der Vartanian, … V. RIBES·bioRxiv·May 18, 2020
- Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo
Jack P. Kucinski, Alexi M Tallan, … Genevieve C. Kendall·Cell ReportsPeer-reviewed·Jul 1, 2025
- Comparative modes of chromatin engagement by PAX::FOXO1 fusions in rhabdomyosarcoma
Alexi M Tallan, Jack P. Kucinski, … Benjamin Z. Stanton·bioRxiv·Feb 19, 2026
- MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN 1 and is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma
Shabir Zargar, Pawan Kumar Raut, … Frederic G. Barr·Molecular Cancer ResearchPeer-reviewed·Aug 17, 2026